Differential Diagnoses for Polyserositis
The differential diagnosis for polyserositis is broad but systematically categorizable into three major groups: neoplastic disease (most common at 26-30%), autoimmune/inflammatory conditions (17%), and infectious etiologies (~12%), though approximately one-third of cases remain idiopathic despite thorough workup 1, 2.
Primary Diagnostic Categories
Neoplastic Causes (Highest Priority)
- Malignancy represents the single most common identifiable cause of polyserositis in contemporary series
- Lymphoproliferative disorders, including myeloid sarcoma/AML (can present as isolated polyserositis without bone marrow involvement) 3
- Metastatic solid tumors
- Critical caveat: In patients with prior cancer history, polyserositis represents disease recurrence in approximately 64% (9 of 14 patients) 2
Autoimmune/Inflammatory Diseases
Sarcoidosis is a key consideration, particularly when polyserositis occurs with:
- Bilateral hilar adenopathy
- Hepatosplenomegaly
- Elevated serum ACE levels
- Granulomatous lesions on biopsy 4, 5
Systemic lupus erythematosus and other connective tissue diseases 6
Adult-onset Still's disease (AOSD) - diagnosed by Yamaguchi criteria when presenting with:
- Fever
- Arthralgia
- Systemic inflammation
- Elevated acute phase reactants 7
ANCA-associated vasculitides, particularly:
- Eosinophilic granulomatosis with polyangiitis (EGPA/Churg-Strauss) - look for asthma, peripheral eosinophilia (>1500 cells/μL), and p-ANCA/MPO positivity 8
- Granulomatosis with polyangiitis - check MPO and PR3 antibodies 4
Infectious Etiologies
- Tuberculosis (especially in developing countries) 9
- Bacterial infections (purulent pericarditis)
- Viral infections
- Post-COVID-19 complication (emerging recognition as late sequela) 10
Diagnostic Algorithm
Initial Laboratory Workup
Serum studies with highest discriminatory value:
- ANA positivity significantly associated with autoimmune disease 2
- ANCA panel (MPO/PR3) for vasculitis 8, 4
- Serum ACE and lysozyme for sarcoidosis 4
- Complete blood count (look for eosinophilia >1500 in EGPA, pancytopenia in sarcoidosis) 8, 5
Serous fluid analysis (mandatory):
- Pleural fluid adenosine deaminase (ADA) - elevated levels significantly associated with autoimmune disease 2
- Pleural LDH - increased levels significantly associated with neoplasm 2
- Flow cytometry on all fluid samples (can diagnose myeloid sarcoma/AML) 3
- Cytology for malignant cells
Imaging Studies
- Chest CT: Look for bilateral hilar adenopathy (sarcoidosis), mediastinal masses (lymphoma, thymoma), or lung parenchymal disease 4, 5
- Cardiac MRI/PET: Assess for inflammatory activity in cardiac sarcoidosis 4
- Abdominal imaging: Evaluate for hepatosplenomegaly, lymphadenopathy 4
Tissue Diagnosis
Biopsy is often required when non-invasive testing is inconclusive:
- VATS with pleural/pericardial biopsy
- Lymph node biopsy if adenopathy present
- Bone marrow biopsy to exclude hematologic malignancy 3
- Look for non-caseating granulomas (sarcoidosis) vs. malignant cells vs. vasculitis 4
Critical Clinical Patterns
Pleura + pericardium involvement (83% of cases) is the most common anatomic distribution 2
Red flags for specific diagnoses:
- Prior malignancy → Think recurrence first
- Asthma + eosinophilia → EGPA
- Bilateral hilar adenopathy + erythema nodosum → Löfgren's syndrome (sarcoidosis) 4
- Recent COVID-19 infection → Post-viral polyserositis 10
Common Pitfalls
Do not assume idiopathic disease prematurely - approximately 35% remain unexplained, but this requires excluding all major causes first 1, 2
Sarcoidosis can mimic malignancy - sarcoid-like reactions occur with neoplasms, immune checkpoint inhibitors, and anti-TNF therapy 4
Isolated myeloid sarcoma can present as polyserositis without bone marrow involvement - flow cytometry of fluid is essential 3
In elderly patients with AOSD, disease tends to be more refractory and severe, requiring aggressive immunosuppression 7
The diagnostic approach must be systematic, starting with non-invasive studies (serology, fluid analysis) and progressing to tissue diagnosis when initial workup is non-diagnostic. The high rate of neoplastic causes mandates aggressive pursuit of malignancy, particularly in patients with constitutional symptoms or prior cancer history.